Outlining migrainous through dihydroergotamine–serotonin receptor interactions using quantum biochemistry-Reference-Cited by-同舟云学术

Outlining migrainous through dihydroergotamine–serotonin receptor interactions using quantum biochemistry

Published:2018 Issue:4 Volume:42 Page:2401-2412
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Lima Neto José X.¹²³⁴^ORCID,Soares-Rachetti Vanessa P.¹²³⁴,Albuquerque Eudenilson L.¹²³⁴,Manzoni Vinicius⁵⁶⁷⁴,Fulco Umberto L.¹²³⁴^ORCID

Affiliation:

1. Departamento de Biofísica e Farmacologia

2. Universidade Federal do Rio Grande do Norte

3. Natal-RN

4. Brazil

5. Instituto de Física

6. Universidade Federal de Alagoas

7. Maceio-AL

Abstract

We present the electronic structure of the complex dihydroergotamine–serotonin receptor to unveil new medications to treat migraine and related diseases.

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2018/NJ/C7NJ03645K

Reference93 articles.

1. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

2. Pharmacological treatment of migraine during pregnancy and breastfeeding

3. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine

4. Direct Cost Burden Among Insured US Employees With Migraine

5. Impact of headache in Europe: a review for the Eurolight project

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of protein-protein interactions and hotspot region on the NSP7-NSP8 binding site in NSP12 of SARS-CoV-2;Frontiers in Molecular Biosciences;2024-01-18

2. Immune-oncological drug pembrolizumab;Quantum Chemistry Methods for Oncological Drugs;2024

3. Immune-oncological drug nivolumab;Quantum Chemistry Methods for Oncological Drugs;2024

4. Antibreast cancer oncological drugs;Quantum Chemistry Methods for Oncological Drugs;2024

5. Computational approach;Quantum Chemistry Methods for Oncological Drugs;2024